Reshma Kewalramani became the CEO of Vertex Pharmaceuticals and helped guide one of the biotechnology industry’s leading innovators. Under her leadership, the company advanced the development and commercialization of treatments for serious diseases, translating scientific research into therapies that improved patient outcomes. Her role placed her at the intersection of medicine, science, and business, overseeing the growth of a major biotechnology enterprise. Kewalramani’s success expanded representation in both corporate leadership and life sciences, demonstrating the growing influence of Indian-origin executives in healthcare innovation.
